Sabra Health Care REIT (SBRA) Misses Q3 EPS by 9c; updates guidance

Sabra Health Care REIT (NASDAQ: SBRA) reported Q3 EPS of $0.09, $0.09 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $190.04 million versus the consensus estimate of $187.06 million.

2025 UPDATED GUIDANCE

Sabra is updating 2025 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):

Net Income: $0.655 - $0.665
FFO: $1.465 - $1.475
Normalized FFO: $1.455 - $1.465
AFFO: $1.455 - $1.465
Normalized AFFO: $1.495 - $1.505

For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Battery X Metals adds auto industry advisor to board